The present invention relates to a method of treating a central nervous system disorder, such as a mood disorder (e.g., major depressive disorder) or an anxiety disorder (e.g., general anxiety disorder, social anxiety disorder, post traumatic stress disorder, and panic disorder) with a low dose combination of escitalopram and bupropion.

 
Web www.patentalert.com

< Compounds which potentiate AMPA receptor and uses thereof in medicine

> Modified release formulations of a bupropion salt

> Modified release formulations of a bupropion salt

~ 00538